Plasma donations save lives in fight against COVID-19 pandemic in Turkey
Two men donate plasma at a Turkish Red Crescent center in Gaziantep, southern Turkey, Sept. 11, 2020. (İHA Photo)

In the absence of a vaccine, Turkey relies on drugs and plasma from recovered coronavirus patients. The country increased the plasma donation quota recently, with transplants from one patient now available for 16 patients



Plasma treatment is a complementary therapy that brings hope to coronavirus patients in Turkey as the country strives to decrease the number of new cases. This treatment relies on donations from recovered patients and is being used widely across the country. New technology is helping in increasing the reach of the transplants. Ramazan Saygılı, a senior official from Turkish Red Crescent (Kızılay) which organizes donations, says recovered patients can now donate plasma eight times and thus, help 16 patients.

Turkey started using plasma in April, one month after the first case was reported in the country. Thousands of patients lined up for donations, but plasma from each patient was limited to the treatment of six patients.

Saygılı told Ihlas News Agency (IHA) on Tuesday that anyone between the ages of 19 and 60 who have recovered from the disease can donate plasma after 14 days following complete recovery.

Turkish Red Crescent obtained 19,500 units of plasma from around 10,000 people since April. Plasma was used in the treatment of thousands of patients in 388 hospitals across the country. The charity, already a leading name in blood donation drives, urges more patients to donate while more than 13,000 people are set to contribute to the plasma drive after their quarantine and test processes are completed.

Using blood donated by patients who have recovered from COVID-19, medical experts hope that the serum therapy, tried more recently against SARS and Ebola, will offer effective treatment for the sick and temporary vaccine-like protection for health care workers and those with weak or suppressed immune systems. The therapy tests if giving infusions of survivors' antibody-rich plasma to COVID-19 patients who have been intubated in intensive care units and have begun to show alveolar damage or those having trouble breathing would boost their own body’s defenses to help fight off the virus. Plasma works using the same principle as a vaccine, but unlike a vaccine, any protection would only be temporary and offer passive immunization. A vaccine – which contains weakened or inactivated viruses and bacteria or small parts of them – trains people’s immune systems to make their own antibodies against a target germ. When these germs enter the body again, the immune system now knows how to deal with or defeat them. The plasma infusion approach similarly gives people a temporary dose of someone else’s antibodies that are short-lived and require repeated doses.

1,225 new recoveries

The Turkish Health Ministry Monday reported 1,716 new cases and 63 deaths from COVID-19 within the past 24 hours.

According to daily data released by the ministry, the new infections were identified in more than 112,000 COVID-19 tests carried out over the past 24 hours, bringing the total number of cases in the country to 292,878.

The death toll from coronavirus increased to 7,119 with 63 new fatalities. Meanwhile, the total number of people who have recovered from COVID-19 increased to 260,058, with 1,225 patients declared free of the coronavirus in the past day.

Shortly after the daily data was published, Health Minister Fahrettin Koca said there was no scientific data suggesting a slowdown in the infectiousness of the coronavirus, as he urged people once more to follow precautions. "We can’t fight it alone, but we can overcome it together. Let’s pay attention to the precautions together," he wrote on Twitter.